1. Home
  2. DGICB vs CTKB Comparison

DGICB vs CTKB Comparison

Compare DGICB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DGICB

Donegal Group Inc. Class B

N/A

Current Price

$19.13

Market Cap

654.6M

Sector

Finance

ML Signal

N/A

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$3.58

Market Cap

595.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGICB
CTKB
Founded
1986
1990
Country
United States
United States
Employees
851
N/A
Industry
Property-Casualty Insurers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
654.6M
595.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DGICB
CTKB
Price
$19.13
$3.58
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
416.0
887.7K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
3.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$2.26
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
$8.06
N/A
Revenue Growth
N/A
17.67
52 Week Low
$13.84
$2.37
52 Week High
$20.30
$6.18

Technical Indicators

Market Signals
Indicator
DGICB
CTKB
Relative Strength Index (RSI) 54.00 32.60
Support Level $15.57 $3.28
Resistance Level $19.72 $4.26
Average True Range (ATR) 0.42 0.28
MACD -0.10 -0.12
Stochastic Oscillator 75.11 15.77

Price Performance

Historical Comparison
DGICB
CTKB

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: